SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-17-072945
Filing Date
2017-12-12
Accepted
2017-12-12 16:31:36
Documents
4
Effectiveness Date
2017-12-12

Document Format Files

Seq Description Document Type Size
1 S-8 a17-28314_1s8.htm S-8 98159
2 EX-5.1 a17-28314_1ex5d1.htm EX-5.1 25298
3 EX-23.2 a17-28314_1ex23d2.htm EX-23.2 3527
4 GRAPHIC g283141kmi001.jpg GRAPHIC 2064
  Complete submission text file 0001104659-17-072945.txt   131070
Mailing Address 1000 CONTINENTAL DRIVE SUITE 600 KING OF PRUSSIA PA 19406
Business Address 56 FITZWILLIAM SQUARE DUBLIN L2 2 (610) 816-6640
Nabriva Therapeutics plc (Filer) CIK: 0001641640 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-222003 | Film No.: 171252130
SIC: 2834 Pharmaceutical Preparations